2018 Q3 Form 10-Q Financial Statement

#000156459018028010 Filed on November 07, 2018

View on sec.gov

Income Statement

Concept 2018 Q3
Revenue $458.0M
YoY Change 4.33%
Cost Of Revenue $23.00M
YoY Change 15.0%
Gross Profit $435.0M
YoY Change 3.82%
Gross Profit Margin 94.98%
Selling, General & Admin $318.0M
YoY Change -9.14%
% of Gross Profit 73.1%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $20.00M
YoY Change -28.57%
% of Gross Profit 4.6%
Operating Expenses $346.0M
YoY Change -8.22%
Operating Profit $89.00M
YoY Change 111.9%
Interest Expense $4.000M
YoY Change -200.0%
% of Operating Profit 4.49%
Other Income/Expense, Net -$2.000M
YoY Change
Pretax Income $87.00M
YoY Change 128.95%
Income Tax $18.00M
% Of Pretax Income 20.69%
Net Earnings $69.00M
YoY Change 176.0%
Net Earnings / Revenue 15.07%
Basic Earnings Per Share $0.50
Diluted Earnings Per Share $0.49
COMMON SHARES
Basic Shares Outstanding 137.6M
Diluted Shares Outstanding 140.5M

Balance Sheet

Concept 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $663.0M
YoY Change -13.11%
Cash & Equivalents $663.0M
Short-Term Investments $0.00
Other Short-Term Assets $26.00M
YoY Change 4.0%
Inventory
Prepaid Expenses
Receivables $227.0M
Other Receivables $0.00
Total Short-Term Assets $926.0M
YoY Change -11.13%
LONG-TERM ASSETS
Property, Plant & Equipment $256.0M
YoY Change -3.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $121.0M
YoY Change 72.86%
Total Long-Term Assets $1.266B
YoY Change -3.06%
TOTAL ASSETS
Total Short-Term Assets $926.0M
Total Long-Term Assets $1.266B
Total Assets $2.192B
YoY Change -6.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $226.0M
YoY Change 1406.67%
Accrued Expenses $154.0M
YoY Change 20.31%
Deferred Revenue $73.00M
YoY Change
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $453.0M
YoY Change 7.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $277.0M
YoY Change 21.49%
Total Long-Term Liabilities $277.0M
YoY Change 4.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $453.0M
Total Long-Term Liabilities $277.0M
Total Liabilities $750.0M
YoY Change -19.44%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $12.06M
Shareholders Equity $1.442B
YoY Change
Total Liabilities & Shareholders Equity $2.192B
YoY Change -6.64%

Cashflow Statement

Concept 2018 Q3
OPERATING ACTIVITIES
Net Income $69.00M
YoY Change 176.0%
Depreciation, Depletion And Amortization $20.00M
YoY Change -28.57%
Cash From Operating Activities $14.00M
YoY Change -110.37%
INVESTING ACTIVITIES
Capital Expenditures -$14.00M
YoY Change -6.67%
Acquisitions
YoY Change
Other Investing Activities $1.000M
YoY Change 0.0%
Cash From Investing Activities -$13.00M
YoY Change -7.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.000M
YoY Change -125.0%
NET CHANGE
Cash From Operating Activities 14.00M
Cash From Investing Activities -13.00M
Cash From Financing Activities -1.000M
Net Change In Cash 0.000
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities $14.00M
Capital Expenditures -$14.00M
Free Cash Flow $28.00M
YoY Change -123.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Interest Expense
InterestExpense
11000000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25000000
us-gaap Operating Income Loss
OperatingIncomeLoss
115000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1269000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1235000000
us-gaap Depreciation
Depreciation
57000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-163000000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17000000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
138000000
us-gaap Costs And Expenses
CostsAndExpenses
1120000000
us-gaap Share Based Compensation
ShareBasedCompensation
72000000
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5000000
CY2017Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
10000000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-14000000
CY2018Q3 trip Accounts Receivable And Contract Assets Net Current
AccountsReceivableAndContractAssetsNetCurrent
237000000
CY2017Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
30000000
CY2018Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
663000000
CY2018Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
73000000
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
60000000
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
230000000
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
227000000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
177000000
CY2018Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
131000000
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
112000000
CY2018Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
12056688
us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
4000000
us-gaap Profit Loss
ProfitLoss
105000000
us-gaap Profit Loss
ProfitLoss
65000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
64000000
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
750000000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
10000000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accounting Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">We use estimates and assumptions in the preparation of our unaudited condensed consolidated financial statements in accordance with GAAP. Our estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of our unaudited condensed consolidated financial statements. These estimates and assumptions also affect the reported amount of net income or loss during any period. Our actual financial results could differ significantly from these estimates. The significant estimates underlying our unaudited condensed consolidated financial statements include: (i) recognition and recoverability of goodwill, definite-lived intangibles and other long-lived assets; and (ii) accounting for income taxes.</p></div>
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
227000000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
230000000
CY2018Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
10000000
CY2018Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
59000000
CY2018Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
8000000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
53000000
CY2018Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
518000
trip Income Tax Benefits Associated With Exercise Settlement Of Stock Based Awards
IncomeTaxBenefitsAssociatedWithExerciseSettlementOfStockBasedAwards
10000000
CY2017Q3 trip Income Tax Benefits Associated With Exercise Settlement Of Stock Based Awards
IncomeTaxBenefitsAssociatedWithExerciseSettlementOfStockBasedAwards
1000000
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
193000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
305000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
312000
CY2018Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
2421000
CY2017Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
416000
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
1607000
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
408000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29000000
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26000000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
90000000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
72000000
CY2018Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
7000000
CY2017Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
9000000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
22000000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
27000000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
22000000
CY2017Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
17000000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
68000000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
45000000
CY2018Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3000000
CY2017Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3000000
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0278
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0184
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0266
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0190
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y5M12D
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M25D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y5M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y4M6D
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4022
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4131
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4226
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4152
CY2018Q3 trip Income Tax Benefits Associated With Exercise Settlement Of Stock Based Awards
IncomeTaxBenefitsAssociatedWithExerciseSettlementOfStockBasedAwards
1000000
trip Income Tax Benefits Associated With Exercise Settlement Of Stock Based Awards
IncomeTaxBenefitsAssociatedWithExerciseSettlementOfStockBasedAwards
17000000
CY2018Q3 us-gaap Cash
Cash
421000000
CY2018Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
421000000
CY2018Q3 trip Cash Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost
CashCashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost
663000000
CY2018Q3 trip Cash Cash Equivalents Restricted Cash And Marketable Securities Fair Value
CashCashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
663000000
CY2017Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
673000000
CY2017Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
27000000
CY2017Q4 us-gaap Cash
Cash
663000000
CY2017Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
663000000
CY2017Q4 trip Cash Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost
CashCashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost
735000000
CY2017Q4 trip Cash Cash Equivalents Restricted Cash And Marketable Securities Fair Value
CashCashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
735000000
trip Cash And Cash Equivalents Maximum Maturity Period
CashAndCashEquivalentsMaximumMaturityPeriod
P90D
CY2018Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.207
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.300
CY2017Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.342
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.393
CY2018Q3 trip Income Tax Reconciliation Change In Cost Sharing Treatment Of Stock Based Compensation
IncomeTaxReconciliationChangeInCostSharingTreatmentOfStockBasedCompensation
-1000000
trip Income Tax Reconciliation Change In Cost Sharing Treatment Of Stock Based Compensation
IncomeTaxReconciliationChangeInCostSharingTreatmentOfStockBasedCompensation
-2000000
CY2017Q3 trip Income Tax Reconciliation Change In Cost Sharing Treatment Of Stock Based Compensation
IncomeTaxReconciliationChangeInCostSharingTreatmentOfStockBasedCompensation
-2000000
trip Income Tax Reconciliation Change In Cost Sharing Treatment Of Stock Based Compensation
IncomeTaxReconciliationChangeInCostSharingTreatmentOfStockBasedCompensation
-5000000
CY2018Q3 trip Income Tax Expense Benefit Upon Litigation
IncomeTaxExpenseBenefitUponLitigation
15000000
CY2017 trip Cash And Cash Equivalents Maximum Maturity Period
CashAndCashEquivalentsMaximumMaturityPeriod
P90D
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2582198
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
38.73
CY2018Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
150000000
trip Marketable Securities Long Term Maximum Maturity Period
MarketableSecuritiesLongTermMaximumMaturityPeriod
P3Y
CY2017 trip Marketable Securities Long Term Maximum Maturity Period
MarketableSecuritiesLongTermMaximumMaturityPeriod
P3Y
trip Marketable Securities Long Term Minimum Maturity Period
MarketableSecuritiesLongTermMinimumMaturityPeriod
P1Y
CY2017 trip Marketable Securities Long Term Minimum Maturity Period
MarketableSecuritiesLongTermMinimumMaturityPeriod
P1Y
trip Maximum Remaining Maturity Period For Short Term Securities
MaximumRemainingMaturityPeriodForShortTermSecurities
P12M
CY2017 trip Maximum Remaining Maturity Period For Short Term Securities
MaximumRemainingMaturityPeriodForShortTermSecurities
P12M
trip Minimum Maturity Period For Short Term Securities
MinimumMaturityPeriodForShortTermSecurities
P90D
CY2017 trip Minimum Maturity Period For Short Term Securities
MinimumMaturityPeriodForShortTermSecurities
P90D
trip Derivative Instruments Non Designated As Hedging Instruments Description
DerivativeInstrumentsNonDesignatedAsHedgingInstrumentsDescription
We use foreign currency forward contracts to reduce the effects of foreign currency exchange rate fluctuations on our cash flows primarily for the Euro versus the U.S. Dollar. We do not use derivatives for trading or speculative purposes. Counterparties to foreign currency exchange derivatives consist of major international financial institutions. We monitor our positions and the credit ratings of the counterparties involved and, by policy limits, the amount of credit exposure to any one party. Our foreign currency forward contracts, which we have entered into to date, have not been designated as hedges and typically have had current maturities of less than 90 days.
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3000000
CY2018Q3 trip Number Of Outstanding Derivatives Contracts
NumberOfOutstandingDerivativesContracts
0
CY2017Q4 trip Number Of Outstanding Derivatives Contracts
NumberOfOutstandingDerivativesContracts
0
CY2018Q3 us-gaap Cost Method Investments
CostMethodInvestments
12000000
CY2017Q4 us-gaap Cost Method Investments
CostMethodInvestments
12000000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018Q3 trip Income Tax Expense Benefit Related To Transition Tax
IncomeTaxExpenseBenefitRelatedToTransitionTax
2000000
trip Income Tax Expense Benefit Related To Transition Tax
IncomeTaxExpenseBenefitRelatedToTransitionTax
2000000
CY2018Q3 trip Federal Tax Return Overpayment Reclassified As Other Long Term Liabilities
FederalTaxReturnOverpaymentReclassifiedAsOtherLongTermLiabilities
25000000
CY2018Q3 trip Transition Tax Repayment Period
TransitionTaxRepaymentPeriod
P8Y
CY2018Q3 trip Remaining Unpaid Transition Tax Included In Other Long Term Liabilities
RemainingUnpaidTransitionTaxIncludedInOtherLongTermLiabilities
31000000
CY2018Q3 trip Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
-3000000
trip Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
-6000000
CY2018Q3 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
14000000
CY2018Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2017Q3 trip Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
95000000
trip Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
335000000
trip Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
269000000

Files In Submission

Name View Source Status
0001564590-18-028010-index-headers.html Edgar Link pending
0001564590-18-028010-index.html Edgar Link pending
0001564590-18-028010.txt Edgar Link pending
0001564590-18-028010-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
trip-10q_20180930.htm Edgar Link pending
trip-20180930.xml Edgar Link completed
trip-20180930.xsd Edgar Link pending
trip-20180930_cal.xml Edgar Link unprocessable
trip-20180930_def.xml Edgar Link unprocessable
trip-20180930_lab.xml Edgar Link unprocessable
trip-20180930_pre.xml Edgar Link unprocessable
trip-ex311_10.htm Edgar Link pending
trip-ex312_8.htm Edgar Link pending
trip-ex321_9.htm Edgar Link pending
trip-ex322_7.htm Edgar Link pending